Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
Objective: Limited data about the prognostic significance of BCL2 mutations and BCL2 copy number variations in diffuse large B-cell lymphoma (DLBCL) are available. This study aimed to comprehensively describe BCL2 genetic alterations in DLBCL patients, and examine correlation of BCL2, TP53 and other...
Main Authors: | Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang, Yuankai Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2022-06-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/19/6/893 |
Similar Items
-
Expression of apoptosis regulating proteins p53 and bcl-2 in psoriasis
by: Nikhil Moorchung, et al.
Published: (2015-01-01) -
A study of Bcl-2 and p-53 immunostaining expressions in colonic carcinomas
by: K Shashi Kiran, et al.
Published: (2016-01-01) -
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
by: Xinyi Li, et al.
Published: (2023-10-01) -
The Comparison of Cytology and Biomarker (P53 and Bcl2) Analysis in Cervical Neoplasia: A Prospective Study
by: Anila Sinha, et al.
Published: (2022-06-01) -
Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
by: Nur Gokhan, et al.
Published: (2022-11-01)